Optogenetics integrates genetic engineering and optics to control and monitor specific cells, like neurons, using light.
Researchers introduce genes encoding photosensitive proteins (opsins) into cells, allowing control with high temporal and spatial resolution.
Karl Deisseroth pioneered optogenetics in the mid-2000s, enabling precise neural circuit control with Channelrhodopsin-2.
The technique combines genetics and optics for on-demand control of excitable cells, modulating neural excitability with light.
Light-sensitive proteins like Channelrhodopsin-2 or Halorhodopsin are commonly used to either excite or suppress neural activity.
Genetic delivery methods like viral vectors or transgenic animal lines are employed to express opsins in targeted cells.
Light delivery methods include optical fibers or miniaturized LEDs/lasers implanted to illuminate specific brain regions in living animals.
Optogenetics has revolutionized neuroscience by allowing precise control over neuronal firing, mapping neural circuits, and linking brain activity to behavior.
Potential medical applications include vision restoration, neurological and psychiatric disorder treatments, and cardiac arrhythmia control using optogenetic therapies.
Recent advancements in optogenetics include engineered opsins for improved features, advanced light delivery systems, and wireless multi-site stimulation technologies.